# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001021771-24-000025
Filing Date
2024-02-01
Accepted
2024-02-01 16:43:48
Documents
17
Period of Report
2024-02-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRESS RELEASE RE PRELIMINARY PHASE 2 CLINICAL TRIAL | bio8k2124.htm iXBRL | 8-K | 25247
2 | PRESS RELEASE | ex99_1.htm | EX-99.1 | 993
6 |  | image00001.jpg | GRAPHIC | 1033690
7 |  | image00002.jpg | GRAPHIC | 629410
| Complete submission text file | 0001021771-24-000025.txt |  | 2451541

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | brtx-20240201.xsd | EX-101.SCH | 3884
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | brtx-20240201_lab.xml | EX-101.LAB | 22547
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | brtx-20240201_pre.xml | EX-101.PRE | 16057
18 | EXTRACTED XBRL INSTANCE DOCUMENT | bio8k2124_htm.xml | XML | 4058

Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

EIN.: 911835664 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37603 | Film No.: 24587575
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)